The india generic injectable market is set for substantial expansion, driven by increasing healthcare needs, government support, and a rising demand for cost-effective treatment options. According to industry projections, the market is expected to grow at a steady rate of 3.7%, reaching USD 16.1 million by 2035 from USD 11.2 million in 2025. Stay Updated …